Crossmark

Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis

Crossref DOI link: https://doi.org/10.1016/j.htct.2024.03.006

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Américo, André Dias https://orcid.org/0000-0002-7980-4540
Silva, Cinthya Correa

Kerbauy, Mariana Nassif

Arcuri, Leonardo Javier

Ribeiro, Andressa Alice Feitosa

Hamerschlak, Nelson https://orcid.org/0000-0002-5140-5310
Santos, Fábio Pires Souza
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2024-05-08
More Information

This article is maintained by: Elsevier

Article Title: Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2024.03.006

Content Type: simple-article

Copyright: © 2024 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below